Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease
- 31 August 2007
- journal article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 28 (8), 1206-1214
- https://doi.org/10.1016/j.neurobiolaging.2006.06.003
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic MiceJournal of Neuroscience, 2006
- Inhibition of Neprilysin by Infusion of Thiorphan into the Hippocampus Causes an Accumulation of Amyloid β and Impairment of Learning and MemoryThe Journal of pharmacology and experimental therapeutics, 2005
- cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor‐3 and scavenger receptor‐AI/II in microglia and macrophagesGlia, 2005
- Neprylisin decreases uniformly in Alzheimer's disease and in normal agingFEBS Letters, 2005
- Presenilin-Dependent Transcriptional Control of the Aβ-Degrading Enzyme Neprilysin by Intracellular Domains of βAPP and APLPNeuron, 2005
- Gene structure and organization of the human β‐secretase ( BACE ) promoterThe FASEB Journal, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Monoamine neurons in aging and Alzheimer's diseaseJournal of Neural Transmission, 1993
- Effects of the selective noradrenergic neurotoxin DSP4 on cerebellar Purkinje neuron electrophysiologyLife Sciences, 1984
- The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous systemMechanisms of Ageing and Development, 1983